• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS CMV IGM IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS CMV IGM IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number ASKU
Device Problem False Positive Result (1227)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/06/2021
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi) #: (b)(4).The country of origin is (b)(6).The investigation is ongoing.The expiration date was provided as june 2021.
 
Event Description
The initial reporter complained of questionable elecsys toxo igm results and elecsys cmv igm immunoassay results for 1 patient sample on a cobas 6000 e 601 module analyzer serial number (b)(4).This medwatch will cover the cmv igm reagent.Refer to the medwatch with patient identifier (b)(6) for information related to the toxo igm reagent.The sample was tested with the elecsys cmv igm assay resulting in a value of 1.62 coi (reactive).The sample was repeated on the vidas biomérieux cmv igm assay resulting in a "negative" value.The specific result was not provided.The sample was tested twice with the elecsys toxo igm assay resulting in values of 3.73 coi (reactive) and 3.72 coi (reactive).The sample was repeated on the vidas biomérieux toxo igm assay resulting in a value of <0.55 index (non-reactive).It was unknown if the results were reported outside the laboratory.
 
Manufacturer Narrative
The sample was provided for investigation where the toxo igm results could be reproduced.The investigation determined the sample contains an interferent to the ruthenium component for both toxo igm and cmv igm.This particular patient sample is not suitable for elecsys toxo igm and cmv igm, due to the ruthenium label used in these assays.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to immunological components, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the elecsys toxo igm and cmv igm assays performed within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS CMV IGM IMMUNOASSAY
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11387855
MDR Text Key268479547
Report Number1823260-2021-00597
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
PMA/PMN Number
K142133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot Number484045
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/29/2021
Initial Date FDA Received02/26/2021
Supplement Dates Manufacturer Received01/29/2021
Supplement Dates FDA Received03/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-